Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

CERILLIANT™ (+/-)-Norpropoxyphene-d5 maleate Solution, 100 μg/mL in Methanol, Sold by MilliporeSigma™ Supelco™

Catalog No. 01001788 Shop All MilliporeSigma Supelco Products
Change view
Click to view available options
Quantity:
1 mL
1 product options available for selection
Product selection table with 1 available options. Use arrow keys to navigate and Enter or Space to select.
Catalog No. Quantity
01-001-788 1 mL
Use arrow keys to navigate between rows. Press Enter or Space to select a product option. 1 options available.
1 options
Catalog No. 01-001-788 Supplier MilliporeSigma Supelco Supplier No. N9041ML
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

Certified reference material

Norpropoxyphene is a major urinary metabolite of propoxyphene, an opioid analgesic drug used for the treatment of pain. Norpropoxyphene's toxicity makes the parent drug more likely to cause death from overdose compared to similar mild opioid analgesics. Suitable use of this stable-labeled internal standard includes quantitation of norpropoxyphene levels by GC/MS or LC/MS in testing applications such as clinical toxicology, urine drug testing, isotope dilution methods or pain prescription monitoring.
TRUSTED_SUSTAINABILITY

Specifications

CAS 67-56-1, 136765-47-4
Linear Formula C21D5H22NO2 · C4H4O4
MDL Number MFCD00673301
UN Number UN 1230 - class 3 - PG 2 - Methanol, solution
Concentration 100 μg/mL in methanol (as free base)
Formula Weight 446.55
Packaging Ampule
Quantity 1 mL
Flash Point 9.7°C (49.5°F) - closed cup

CERILLIANT is a registered trademark of Cerilliant Corporation

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.